Effects of Adiponectin on Breast Cancer Cell Growth
Author Information
Author(s): Grossmann M E, Nkhata K J, Mizuno N K, Ray A, Cleary M P
Primary Institution: Hormel Institute, University of Minnesota
Hypothesis
Adiponectin may negatively regulate breast cancer growth and signaling.
Conclusion
Adiponectin inhibits the growth of certain breast cancer cell lines, particularly those that are estrogen receptor positive.
Supporting Evidence
- Adiponectin levels are lower in obese individuals, which may contribute to breast cancer risk.
- Breast cancer cell lines expressed adiponectin receptors, indicating potential responsiveness to adiponectin.
- Adiponectin inhibited growth in estrogen receptor positive cell lines at lower concentrations than in negative ones.
- Increased apoptosis was observed in ER-positive cell lines treated with adiponectin.
Takeaway
Adiponectin, a protein related to fat, can help slow down the growth of some breast cancer cells, especially in women who have gone through menopause.
Methodology
The study involved in vitro assays using five breast cancer cell lines to assess the effects of adiponectin on cell growth and signaling pathways.
Limitations
The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website